Reforming the institutional review board process, with an eye toward streamlining clinical trials, is expected to be a focus of forthcoming draft legislation from the House Energy and Commerce Committee’s 21st Century Cures initiative.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?